159 related articles for article (PubMed ID: 61803)
1. Cell lines derived from teratocarcinomas.
Nicolas JF; Avner P; Gaillard J; Guenet JL; Jakob H; Jacob F
Cancer Res; 1976 Nov; 36(11 Pt. 2):4224-31. PubMed ID: 61803
[TBL] [Abstract][Full Text] [Related]
2. [Experimental teratocarcinoma in mice: a model system for the study of the relationship between cellular surface antigens and embryonic differentiation].
Gachelin G
Bull Cancer; 1976; 63(1):95-110. PubMed ID: 62594
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of the pluripotent mouse teratocarcinoma cell line TCE.
Wobus AM; Holzhausen H; Bloch C; Intek A; Becker K; Walter G; Forejt J; Schöneich J
Biomed Biochim Acta; 1985; 44(11-12):1609-20. PubMed ID: 4091834
[TBL] [Abstract][Full Text] [Related]
4. Clonal lines of teratocarcinoma cells in vitro: differentiation and cytogenetic characteristics.
McBurney MW
J Cell Physiol; 1976 Nov; 89(3):441-55. PubMed ID: 988033
[TBL] [Abstract][Full Text] [Related]
5. Microfluoremetric analysis of DNA content changes in murine teratocarcinoma.
Swartzendruber DE; Cram LS; Lehman JM
Cancer Res; 1976 Jun; 36(6):1894-9. PubMed ID: 944615
[TBL] [Abstract][Full Text] [Related]
6. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.
Swartzendruber DE; Lehman JM
J Cell Physiol; 1975 Apr; 85(2 Pt 1):179-87. PubMed ID: 164473
[TBL] [Abstract][Full Text] [Related]
8. The characterization of SV40-transformed cell lines derived from mouse teratocarcinoma: growth properties and differentiated characteristics.
Topp W; Hall JD; Rifkin D; Levine AJ; Pollack R
J Cell Physiol; 1977 Nov; 93(2):269-76. PubMed ID: 201648
[TBL] [Abstract][Full Text] [Related]
9. Of mice and men: teratomas and teratocarcinomas.
Bulić-Jakus F; Ulamec M; Vlahović M; Sincić N; Katusić A; Jurić-Lekć G; Serman L; Kruslin B; Belicza M
Coll Antropol; 2006 Dec; 30(4):921-4. PubMed ID: 17243571
[TBL] [Abstract][Full Text] [Related]
10. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
[TBL] [Abstract][Full Text] [Related]
11. In vitro growth and differetiation of clonal populations of multipotential mouse clls derived from a transplantable testicular teratocarcinoma.
Rosenthal MD; Wishnow RM; Sato GH
J Natl Cancer Inst; 1970 May; 44(5):1001-14. PubMed ID: 4936569
[No Abstract] [Full Text] [Related]
12. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
Lehtonen E; Laasonen A; Tienari J
Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract][Full Text] [Related]
14. Morphological and biochemical observations on cells derived from the in vitro differentiation of the embryonal carcinoma cell line PCC4-F.
Chung AE; Estes LE; Shinozuka H; Braginski J; Lorz C; Chung CA
Cancer Res; 1977 Jul; 37(7 Pt 1):2072-81. PubMed ID: 558822
[No Abstract] [Full Text] [Related]
15. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.
Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J
Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of peanut agglutinin-resistant embryonal carcinoma cell-surface variants.
Rosenstraus MJ; Hannis M; Kupatt LJ
J Cell Physiol; 1982 Aug; 112(2):162-70. PubMed ID: 6126483
[TBL] [Abstract][Full Text] [Related]
17. From stem cells to germ cell tumors and back.
Damjanov I
Verh Dtsch Ges Pathol; 2004; 88():39-44. PubMed ID: 16892532
[TBL] [Abstract][Full Text] [Related]
18. Human embryonic stem cell lines derived from the Chinese population.
Fang ZF; Jin F; Gai H; Chen Y; Wu L; Liu AL; Chen B; Sheng HZ
Cell Res; 2005 May; 15(5):394-400. PubMed ID: 15916726
[TBL] [Abstract][Full Text] [Related]
19. Visceral yolk sac-derived tumors.
Sobis H; Verstuyf A; Vandeputte M
Int J Dev Biol; 1993 Mar; 37(1):155-68. PubMed ID: 8389575
[TBL] [Abstract][Full Text] [Related]
20. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
